Michael Dieterle

Title: Michael Dieterle: Innovator in Antibody Enrichment

Introduction

Michael Dieterle is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of immunology through his innovative work on antibody enrichment processes. His expertise and dedication to research have led to advancements that benefit various applications in medicine and biotechnology.

Latest Patents

Michael Dieterle holds a patent for the selective enrichment of antibodies. This invention relates to a process for the selective concentration of immunoglobulins or other proteins that contain an Fc domain, known as the target protein. The process involves several steps that enhance the efficiency of antibody concentration, which is crucial for various therapeutic and diagnostic applications. He has 1 patent to his name.

Career Highlights

Michael Dieterle is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to work on cutting-edge research and development projects that aim to improve healthcare solutions. His contributions have been instrumental in advancing the company's mission to deliver innovative medicines.

Collaborations

Michael collaborates with talented colleagues, including Dorothee Ambrosius and Philine Dobberthien. Together, they work on various projects that leverage their combined expertise in immunology and biotechnology.

Conclusion

Michael Dieterle's work in the selective enrichment of antibodies showcases his innovative spirit and commitment to advancing medical science. His contributions are paving the way for new therapeutic possibilities and enhancing the understanding of immunological processes.